Owner Abbott GmbH & Co. KG Abbott Laboratories

Inventors Akritopoulou-Zanze, Irini; Braje, Wilfried; Djuric, Stevan W.; Wilson, Noel S.; Turner, Sean C.; Kruger, Albert W.; Relo, Ana-Lucia; Shekhar, Shashank; Welch, Dennie S.; Zhao, Hongyu; Gandarilla, Jorge; Gasiecki, Alan F.; Li, Huanqiu; Thompson, Christina M.; Zhang, Min

Agent Spruson & Ferguson

Pub. Number AU-A-2010249472

PCT Pub. Number WO2010/135560

Priority 61/180,569 22.05.09 US

Filing date 20 May 2010

Wipo publication date 25 November 2010

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms